February 12, 2016 / 7:37 AM / 2 years ago

BRIEF-Karo Bio posts bigger Q4 loss, announces rights issue 

Feb 12 (Reuters) -

* Karo bio ab says net sales increased to msek 69.1 (30.1), whereof q4 msek 57.4 (8.1)

* Karo bio ab says board of directors proposes that parent company changes name to karo pharma ab

* Net loss was MSEK 78.2 (-59.3), whereof q4 msek -24.7 (-21.8)

* Karo bio ab says underwriting agreements have been obtained for 100 per cent of issue, of which chairman Anders Lönner underwrites over 97 per cent. (Reporting By Johan Ahlander)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below